This biotech comes with high hopes and question marks.
Regeron's technicals -- and the current pullback -- all add up to a buy.
This rollup name is on the stock-market equivalent of steroids.
Any remedies for managed-care companies and Medicaid HMOs?
Kindred Biosciences is a unique player in an underserved market.
Healthy additions to your portfolio.

Abbott Labs Breaks Out Real Money Pro($)

Bullish action has set the stock up well for more upside.

Making a Plan for Spectrum Real Money Pro($)

You can add to long with close above $8.57.
Here's how to trade it at this point.

Get Mad, Then Average Down Real Money Pro($)

Sometimes a buy goes against you, even if the fundamentals are solid.

Columnist Conversations

This morning's Markit Manufacturing PMI figures out of Europe offer a mixed bag, but there were two disappoint...
1100 Handle May be Around the Corner
The action in the DOW today was the reverse of what we saw yesterday in the index. The rally off the lows in t...
The visualization of data is provided by Capital Market Laboratories (CML). Z is trading $115.95, down 2.8% w...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.